pharma regulatory affairs
Regulators Adapt to Increasingly Globalised Pharmaceutical Industry
December 22 by Pharma IQEmerging markets are expected to be responsible for much of the growth within the pharmaceutical industry in the coming years. IMS health predicts the markets it describes as pharmerging will gro...
Effective Information Management to Aid Regulatory Submissions: What Do You Do to Make it Work in Practice?
September 13 by Helen WinsorPharmaceutical companies are placing even more importance on the pharma regulatory aspects of data and information management and how efficiently information is translated to drug...
Career Spotlight: Pharma Regulatory Affairs
August 31 by Pharma IQProfessionals must combine knowledge of the business, legal and pharmaceutical industries to determine if regulations are being followed and in many cases form the link between pharma companies and re...
Building a Common Language: Boehringer Ingelheim Pharma GmbH & Co. KG on Interaction with Regulatory Bodies
April 19 by Torsten GrünewaldIn this exclusive interview Dr. Torsten Grünewald - Lead Business Architect at Boehringer Ingelheim Pharma GmbH & Co. KG expresses the need for a common language when interacting with...